Vaxxinova, headquartered in The Netherlands, acquires Laboratório Biovet
PRESS RELEASE VARGEM GRANDE PAULISTA, SAO PAULO, February 1, 2018. Vaxxinova, a subsidiary of the EW Group, has acquired Laboratório Biovet, a Brazilian company with 60 years of commitment to the animal health industry.
Biovet was founded in 1957 by veterinarian René Corrêa, and has remained a family-owned company since then. The company is strongly positioned in the Brazilian animal health industry and exports to more than 10 countries. Biovet has several leading brands including Bio-Coccivet R® (vaccine against Avian Coccidiosis), Resguard Multi® (vaccine against Clostridiosis) and Vermivet® (a dewormer for companion animals).
In respect to the transaction, Hugo Scanavini Neto, CEO of Laboratório Biovet said: “Biovet and Vaxxinova share the same principles and values, with people and clients being the highlight of our businesses. We also share the same passion for science in animal health. This transaction provides Biovet access to an international network and strengthens the strategic steps already in place, with outstanding results in innovation and growth, along with international expansion. It also represents the consolidation of the professionalization of the management of the company, which started 7 years ago, and that now will have the support of a global platform”.
Victor van Solinge, CEO from Vaxxinova International added: “We are pleased to welcome Biovet to the Vaxxinova Group. Biovet has a long-standing reputation in the Brazilian Animal Health market with a strong management team and has an excellent product portfolio. The new combination will allow us to grow even faster and offer a wider product and service portfolio to our customers. We see an excellent fit between the companies, since we have similar cultures, complementary strengths and have the same long term commitment to the industry”.
About Laboratório Biovet
Laboratório Biovet, with headquarters in Vargem Grande Paulista, São Paulo State, Brazil, has 450 employees and more than 100 licensed products. Its executive directors and employees possess extensive experience in the animal health industry in Brazil and Latin America. Biovet has its own research center and production complex, which enables the company to develop, manufacture and market the best solutions in animal health in the Cattle, Poultry and Companion Animal segments.
Vaxxinova is an animal health global player specialized in disease and performance management of production animals. The company operates in more than 50 countries and has its headquarters in Nijmegen, The Netherlands, with R&D, production and diagnostic facilities in Germany, Italy, Norway, Japan, Jordan, the Netherlands, and now, Brazil. Vaxxinova is part of the family-owned EW Group.
About EW Group
EW Group, with headquarters in Visbek, Germany, is a 100% family-owned holding company and is specialized in animal genetics, animal nutrition and animal health.
BIOVET: Alessandro Mancio de Camargo, MTb 24.440, EiraCom – Public relations: +55 (11) 3042 0765 / (15) 9 9773 6355, firstname.lastname@example.org
VAXXINOVA: +31 (0) 24 2048600, email@example.com.